Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth.
Tocheny CE, Buchwald JE, Dahlke CD, Fakih HH, Morgan JS, Summers A, Wisniewski CA, Jackson SO, Lee JS, Card MA, Echeverria D, Peterson C, Mercurio AM, Khvorova A, Shaw LM.
Tocheny CE, et al. Among authors: morgan js.
bioRxiv [Preprint]. 2025 Aug 1:2025.07.29.667434. doi: 10.1101/2025.07.29.667434.
bioRxiv. 2025.
PMID: 40766531
Free PMC article.
Preprint.